phacidin has been researched along with navitoclax in 1 studies
Studies (phacidin) | Trials (phacidin) | Recent Studies (post-2010) (phacidin) | Studies (navitoclax) | Trials (navitoclax) | Recent Studies (post-2010) (navitoclax) |
---|---|---|---|---|---|
6 | 0 | 1 | 429 | 15 | 401 |
Protein | Taxonomy | phacidin (IC50) | navitoclax (IC50) |
---|---|---|---|
Bcl-2-like protein 11 | Homo sapiens (human) | 0.0043 | |
Apoptosis regulator Bcl-2 | Homo sapiens (human) | 0.0091 | |
Bcl-2-like protein 1 | Homo sapiens (human) | 0.0168 | |
Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 1.0925 | |
Bcl-2-like protein 2 | Homo sapiens (human) | 0.07 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dorjsuren, D; Egli, M; Eoff, RL; Jadhav, A; Lloyd, RS; Maloney, DJ; Simeonov, A; Yamanaka, K | 1 |
1 other study(ies) available for phacidin and navitoclax
Article | Year |
---|---|
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
Topics: Acrolein; Benzimidazoles; Biphenyl Compounds; Cell Line, Transformed; Cell Survival; Deoxyguanosine; DNA; DNA Adducts; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Indoles; Nucleic Acid Synthesis Inhibitors; Small Molecule Libraries; Terpenes; Tetrazoles; Ultraviolet Rays | 2012 |